See you in court: Mallinckrodt takes on feds to fight $600M in back Acthar rebates

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 21, 2019 at 11:02 PM.

  1. #1 cafead, May 21, 2019 at 11:02 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,925
    Likes Received:
    3
    via Mallinckrodt’s Acthar Gel is no stranger to controversy. Pricing critics, payers, and the feds have all targeted the controversial hormone injection. But now, Medicaid is hitting Acthar where it hurts most—in the pocketbook—and the company is more than happy to go to court.

    article source
     
    Quote

Reply to Thread